Clinical Research Directory
Browse clinical research sites, groups, and studies.
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Sponsor: UNICANCER
Summary
The goal of this clinical trial is to assess whether adding telemonitoring (the digital telemonitoring platform "CUREETY TECHCARE"), to standard care, will benefit patients with previously untreated metastatic triple-negative breast cancer starting first-line cancer therapy. The main questions it aims to answer are: * Is patient quality of life improved by using the telemonitoring platform? * Are patients hospitalized less frequently when using the telemonitoring platform? * Is the patient overall survival improved by telemonitoring ? Researchers will compare data from patients using telemonitoring while receiving standard care with data from patients receiving only standard care. Participants using telemonitoring will answer questions about their symptoms on the platform. The platform will analyze these symptoms, assess the patient's general condition and provide advice accordingly. Medical staff will also access the platform to monitor the patient's general condition and contact them if necessary.
Official title: A Randomized Phase III Study Comparing the Digital Telemonitoring Platform "CUREETY TECHCARE" to Usual Standard of Care in Patients With Triple Negative Metastatic Breast Cancer Initiating a First-line Systemic Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
472
Start Date
2024-07-25
Completion Date
2028-09-02
Last Updated
2025-09-02
Healthy Volunteers
No
Interventions
Cureety techcare
Each week, patients complete a questionnaire via the Cureety platform, specifically designed for the drug class or specific treatment being administered. Based on their responses, the Cureety TechCare algorithm classifies patients into one of four risk categories: "correct" (green), "compromised" (yellow), "state to be monitored" (orange), or "critical state" (red). (Note: the color code is not visible to the patient). The medical team uses the dashboard for daily patient monitoring and manages alerts related to the "clinical classification" of the patient's condition. The physician in charge of telemonitoring interprets the data, adjusts the treatment as needed, and provides supportive care during standard care consultations. Patients are also notified of alerts with tailored messages guiding them on the actions to take according to the category determined by the device.
Locations (51)
Institut de Cancérologie des Hauts-de-France (ICHF)
Arras, France
Centre Hospitalier d'Auxerre
Auxerre, France
Sainte Catherine - Institut du Cancer Avignon Provence
Avignon, France
CH Aunay-Bayeux
Bayeux, France
Centre Hospitalier Simone Veil de Beauvais
Beauvais, France
ICHF - Centre Pierre Curie
Beuvry, France
Hôpital Simone Veil de Blois
Blois, France
Polyclinique bordeaux nord
Bordeaux, France
Centre Hospitalier Fleyriat
Bourg-en-Bresse, France
Centre de Cancérologie Privé de Caen Maurice Tubiana
Caen, France
Centre Francois Baclesse
Caen, France
Centre hospitalier de Carcasonne
Carcassonne, France
Recherche Oncologie Clinqiue 37 (ROC 37)
Chambray-lès-Tours, France
CH de Cholet
Cholet, France
CH Colmar
Colmar, France
Groupe Hospitalier Public du Sud de l'Oise (GHPSO)
Creil, France
Centre Georges François Leclerc
Dijon, France
Institut Andrée Dutreix
Dunkirk, France
CH Annecy Genevois
Épagny, France
Centre Hospitalier Intercommunal de Fréjus Saint Raphael
Fréjus, France
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, France
CHU de la réunion
La Réunion, France
Clinique Sainte Clotilde
La Réunion, France
Groupe Hospitalier de La Rochelle-Ré-Aunis
La Rochelle, France
CHU Grenoble Alpes
La Tronche, France
Centre Hospitalier Louis Pasteur
Le Coudray, France
Centre Hospitalier Le Mans
Le Mans, France
Centre Hospitalier Emile Roux
Le Puy-en-Velay, France
GHBS Lorient
Lorient, France
Centre Leon Berard
Lyon, France
Clinique de la Sauvegarde
Lyon, France
Hôpital Privé Jean Mermoz
Lyon, France
Institut Paoli Calmettes
Marseille, France
CHI de Mont-de-Marsan et du Pays des Sources
Mont-de-Marsan, France
Centre de Cancérologie du Grand Montpellier
Montpellier, France
Hôpital Privé du Confluent
Nantes, France
Clinique Ambroise-Pare Hartmann
Neuilly-sur-Seine, France
Hôpital Américain de PARIS
Neuilly-sur-Seine, France
CHU de Nimes
Nîmes, France
CHR Orleans
Orléans, France
CHP Sainte-Marie
Osny, France
Diaconesses Croix Saint-Simon Hospital Complex
Paris, France
Centre hospitalier de Pau
Pau, France
CARIO - Hopital Privé des Cotes d'Armor
Plérin, France
CHU de Poitiers
Poitiers, France
Institut Godinot
Reims, France
Clinique Mathilde - Les Hôpitaux Privés Rouennais
Rouen, France
CHU de Saint-Etienne
Saint-Etienne, France
Hia Begin
Saint-Mandé, France
CHU de Tours
Tours, France
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France